TapewireFind a company

organization · Reporting owner

Squadron Capital Holdings LLC

Disclosed activity across 2 companies

Tapewire entity
10145
SEC CIK
0001731171

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Alphatec Holdings, Inc.ATEC · Entity 472010% ownerDecember 08, 2025December 10, 2025
ORTHOPEDIATRICS CORPKIDS · Entity 533810% ownerSeptember 10, 2026September 11, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Alphatec Holdings, Inc.

Report date December 08, 2025 · Filed December 10, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee footnote10,645,045 Last balance in matching sequence After 2025-12-09 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 1 · 2025-12-08 · Sale · Disposed 221,166 · Balance 10,673,879

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.42 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2: These shares are held of record by Squadron Capital LLC ("Squadron"). Squadron Capital Holdings LLC is the controlling member of Squadron.

Row 2 · 2025-12-09 · Sale · Disposed 28,834 · Balance 10,645,045

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.91 to $21.11 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2: These shares are held of record by Squadron Capital LLC ("Squadron"). Squadron Capital Holdings LLC is the controlling member of Squadron.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.42 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2: These shares are held of record by Squadron Capital LLC ("Squadron"). Squadron Capital Holdings LLC is the controlling member of Squadron.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.91 to $21.11 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

ORTHOPEDIATRICS CORP

Report date September 10, 2026 · Filed September 11, 2026

Jointly reported with Squadron Capital LLC

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect6,201,764 Reported balance After 2026-09-10 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2026-09-10 · Sale · Disposed 302,369 · Balance 6,201,764

F1: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Filing footnotes · ownership attribution and instrument terms

F1: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 10, 2026 Filed Sep 11, 2026 12:30 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 SaleCommon Stock 302,369 $21.01 $6,352,772.69
Disclosure

SEC source: 0001193125-26-388667 · ownership.xml · nonDerivative · entry 1

Squadron Capital LLC · CIK 0001719228 · 10% owner

Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,201,764

F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 20:42 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 SaleCommon Stock 22,500 $23.35 $525,375.00
Disclosure

SEC source: 0001193125-26-383761 · ownership.xml · nonDerivative · entry 1

Squadron Capital LLC · CIK 0001719228 · 10% owner

Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,504,133

F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.01 to $23.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Read SEC document
September 01, 2026 Filed Sep 1, 2026 22:48 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 SaleCommon Stock 10,131 $23.10 $234,026.10
Disclosure

SEC source: 0001193125-26-378892 · ownership.xml · nonDerivative · entry 2

Squadron Capital LLC · CIK 0001719228 · 10% owner

Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,526,633

F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Read SEC document
August 28, 2026 Filed Sep 1, 2026 22:48 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 SaleCommon Stock 326,700 $23.04 $7,527,168.00
Disclosure

SEC source: 0001193125-26-378892 · ownership.xml · nonDerivative · entry 1

Squadron Capital LLC · CIK 0001719228 · 10% owner

Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,536,764

F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Read SEC document
August 26, 2026 Filed Aug 26, 2026 22:29 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 SaleCommon Stock 18,000 $24.28 $437,040.00
Disclosure

SEC source: 0001193125-26-369063 · ownership.xml · nonDerivative · entry 3

Squadron Capital LLC · CIK 0001719228 · 10% owner

Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,863,464

F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.13 to $24.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Read SEC document
August 25, 2026 Filed Aug 26, 2026 22:29 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 SaleCommon Stock 16,300 $24.74 $403,262.00
Disclosure

SEC source: 0001193125-26-369063 · ownership.xml · nonDerivative · entry 2

Squadron Capital LLC · CIK 0001719228 · 10% owner

Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,881,464

F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.53 to $24.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Read SEC document
August 24, 2026 Filed Aug 26, 2026 22:29 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 SaleCommon Stock 4,000 $25.75 $103,000.00
Disclosure

SEC source: 0001193125-26-369063 · ownership.xml · nonDerivative · entry 1

Squadron Capital LLC · CIK 0001719228 · 10% owner

Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,897,764

F1 · kind: This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.50 to $25.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Read SEC document
December 09, 2025 Filed Dec 10, 2025 23:37 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 SaleCommon Stock 28,834 $21.03 $606,379.02
Disclosure

SEC source: 0001193125-25-314542 · ownership.xml · nonDerivative · entry 2

Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 10,645,045

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.91 to $21.11 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: These shares are held of record by Squadron Capital LLC ("Squadron"). Squadron Capital Holdings LLC is the controlling member of Squadron.

Read SEC document
December 08, 2025 Filed Dec 10, 2025 23:37 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 SaleCommon Stock 221,166 $21.20 $4,688,719.20
Disclosure

SEC source: 0001193125-25-314542 · ownership.xml · nonDerivative · entry 1

Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 10,673,879

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.42 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: These shares are held of record by Squadron Capital LLC ("Squadron"). Squadron Capital Holdings LLC is the controlling member of Squadron.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 12:16 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 SaleCommon Stock 250,000 $20.62 $5,155,000.00
Disclosure

SEC source: 0001193125-25-298151 · ownership.xml · nonDerivative · entry 1

Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 10,895,045

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.34 to $20.79 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: These shares are held of record by Squadron Capital LLC ("Squadron"). Squadron Capital Holdings LLC is the controlling member of Squadron.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:20 UTC Alphatec Holdings, Inc. ATEC · Entity 4720 SaleCommon Stock 250,000 $20.80 $5,200,000.00
Disclosure

SEC source: 0001193125-25-283326 · ownership.xml · nonDerivative · entry 1

Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 11,145,045

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.67 to $21.07 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: These shares are held of record by Squadron Capital LLC ("Squadron"). Squadron Capital Holdings LLC is the controlling member of Squadron. These shares were previously reported on a joint filing by Squadron and the reporting person.

Read SEC document
September 20, 2022 Filed Sep 22, 2022 11:34 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 OtherWarrants (right to buy) · Derivative 1,525,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000899243-22-031660 · doc4.xml · derivative · entry 2

Squadron Capital LLC · CIK 0001719228 · 10% owner

Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,525,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days.

F1 · derivative.expiration_date: Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days.

F2 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Read SEC document
September 20, 2022 Filed Sep 22, 2022 11:34 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 OtherCommon Stock 1,525,000 $0.00 $457.50
Disclosure

SEC source: 0000899243-22-031660 · doc4.xml · nonDerivative · entry 1

Squadron Capital LLC · CIK 0001719228 · 10% owner

Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,901,764

F2 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Read SEC document
August 11, 2022 Filed Aug 15, 2022 21:38 UTC ORTHOPEDIATRICS CORP KIDS · Entity 5338 PurchaseWarrants (right to buy) · Derivative 1,525,000 $55.00 Strike: $0.00 $83,874,695.00
Disclosure

SEC source: 0000899243-22-028658 · doc4.xml · derivative · entry 1

Squadron Capital LLC · CIK 0001719228 · 10% owner

Squadron Capital Holdings LLC · CIK 0001731171 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,525,000

Underlying: Common Stock · 1,525,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron Capital LLC is obligated to exercise them within five (5) business days.

F1 · derivative.expiration_date: Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron Capital LLC is obligated to exercise them within five (5) business days.

F2 · ownership.direct: These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.